No. | Author, Year | Duration of diabetes (years) | HbA1 C | Creatine (mg/dl) | CRP (mg/L) | OR (95%CI) of NLR | OR (95%CI) of PLR | OR (95%CI) of MLR | OR (95%CI) of SII |
---|---|---|---|---|---|---|---|---|---|
1 | Abdullah, 2021 [15] | 11.6 ± 3.25 | no DR 6.8 ± 0.4; DR 8.13 ± 0.7 | N/A | N/A | N/A | N/A | N/A | N/A |
2 | Akdogan, 2016 [16] | 15.8 ± 7.3 | no DR 9.2 ± 2.6; DR 9.3 ± 2.0 | N/A | N/A | N/A | N/A | N/A | N/A |
3 | Ciray, 2015 [21] | 9.1 ± 6.5 | no DR 8.7 ± 2.4; DR 9.7 ± 2.1 | DR: 42.2 ± 797 No DR: 54.7 ± 115 | DR 6.64 ± 6.01 no DR 4.78 ± 5.46 | N/A | N/A | N/A | N/A |
4 | Dascalu AM, 2023 (a) [11] |  > 5 years | no DR 7.01 ± 0.972; NPDR 7.33 ± 1.59; PDR 7.25 ± 0.978 | no DR: 0.865 ± 0.215; NPDR 0.97 ± 0.323; PDR 1.3 ± 1.03 | N/A | 2.01 (1.29–3.14)* | 1.01 (1–1.02)* | N/A | N/A |
5 | Dascalu AM, 2023 (b) [10] | No DR 5.3 ± 2.4; NPDR 9.36 ± 3.3; PDR 11 ± 3.1 | No DR 7.2 ± 1.1; NPDR 7.5 ± 1.8; PDR 8.2 ± 1.8 | no DR 0.9 ± 0.3; NPDR 1 ± 0.5; PDR 1.3 ± 0.8 | N/A | 1.645 (1.189–2.275)* |  | 1.662 (1.209–2.284)* | 1.001 (1–1.003)* |
6 | Dogan, 2024 [22] | no DR 8.61 ± 4.22; NPDR 10.8 ± 3.13; PDR 12.8 ± 4.38 | no DR 6.09 ± 2.99; NPDR 7.17 ± 2.63; PDR 7.65 ± 3.79 | N/A | no DR 0.54 ± 0.38; NPDR 0.64 ± 0.29; PDR 0.86 ± 0.31 | N/A | N/A | N/A | N/A |
7 | El-Tawab, 2023 [23] | N/A | no PDR 7.27 ± 1.28; PDR 8.46 ± 1.66; | N/A | N/A | 3.312 (1.262–8.696)* | N/A | N/A | N/A |
8 | Fawwad, 2018 [24] | no DR 10.89 ± 7.38; DR 15.47 ± 8.47 | no DR 9.14 ± 2.27; DR 9.71 ± 2.42 | no DR 1.10 ± 0.65; DR 1.35 ± 0.99 | N/A | 1.766 (1.789–2.093)* | N/A | N/A | N/A |
9 | Gao Y, 2024 [25] | N/A | no DR 6.90 ± 0.19; NPDR 7.64 ± 1.18; PDR 7.73 ± 0.24 | N/A | N/A | 1.122 (0.200–2.043)* | 0.038 (0.018–0.058)* | N/A | 0.007 (0.001–0.01)* |
10 | He X, 2022 [26] | no DR 10.1 ± 4.9; DR 12.9 ± 3.0 | no DR 7.4 ± 1.8; DR 7.9 ± 1.9 | N/A | no DR 0.5 ± 0.7; DR 0.6 ± 0.8 | 1.076 (1.015, 1.142)* | N/A | N/A | N/A |
11 | Huang Q, 2021 [27] | N/A | N/A | N/A | control 2.26 ± 1.77 no DR 6.18 ± 4.39 DR 10.31 ± 6.64 | N/A | N/A | 5.302 (2.925–15.201) | N/A |
12 | Ilhan C, 2019 [28] | N/A | control 5.26 ± 0.44; NPDR 8.12 ± 1.09; PDR 8.32 ± 1.07 | N/A | N/A | N/A | N/A | N/A | N/A |
13 | Ilhan C, 2020 [29] | PDR DME 8.25 ± 4.83; PDR non DME 6.58 ± 2.72 | 7.84 ± 0.87 | N/A | N/A | N/A | N/A | N/A | N/A |
14 | Li J, 2024 [13] | 9.32 ± 7.10 | No DR 8.77 ± 2.67 DR 8.00 ± 2.00 | No DR 0.646 ± 0.160 DR 0.982 ± 0.976 | N/A | 1.93 (1.10–3.40)* | 1.47 (1.14–2.03)* | N/A | 1.47 (1.14–2.03)* |
15 | Moursy, 2015 [32] | no DR 10.21 ± 5.74; DR 9.78 ± 7.40 | DR 10.28 ± 2.50; no DR 8.62 ± 2.63 | no DR 1.41 ± 0.30; DR 2.52 ± 1.21 | N/A | N/A | N/A | N/A | N/A |
16 | Ozturk, 2013 [33] | no DR 6.15 ± 3.22 DR 8.44 ± 4.62; | no DR 9.28 ± 2.54; DR 9.93 ± 2.30 | no DR 0.80 ± 0.62; DR 0.97 ± 0.88 | no DR 25.72 ± 25.40; DR 15.26 ± 14.14 | 1.904 (1.170–3.100)* | N/A | N/A | N/A |
17 | Sari, 2021 [35] | N/A | N/A | N/A | N/A | 2.765 (1,045–7,315)* | 1 (1–1) | 0,00 (0,00–1,49) | N/A |
18 | Tang Y, 2024 [36] | no DR 46.75 ± 32.41 DR 87.25 ± 43.17 | no DR 7.50 ± 1.93; DR 8.10 ± 2.19 | no DR 0.72 ± 0.18 DR 0.70 ± 0.20 | N/A | 1.292 (1.112–1.501)* | N/A | N/A | N/A |
19 | Ulu SM, 2013 [37] | 7.33 ± 7.16 | N/A | 0.78 ± 0.31 | no DR 0.82 ± 0.55; DR 2.59 ± 2.58 | N/A | N/A | N/A | N/A |
20 | Wan H, 2020 [38] | 10.75 ± 3.25 | N/A†| N/A†| N/A†| DR 1.09 (0.82–1.45) NPDR (1.06 (0.80–1.42) PDR 0.94 (0.23–3.86) | N/A | N/A | N/A |
21 | Wang JR, 2020 [39] | no DR 66.16 ± 66.25; DR 122.86 ± 87.38 months | no DR 9.68 ± 2.66; DR 9.96 ± 2.45 | no DR 0.78 ± 0.20; DR 0.95 ± 0.53 | N/A | 1.37 (1.06–1.78)* | 1.05 (0.99- 1.11) | 0.96 (0.82–1.13) | N/A |
22 | Wang RT, 2015 [40] | no DR 2.7 ± 1.7; DR 8.6 ± 1.7 | no DR 6.9 ± 1.1; DR 7.7 ± 0.7 | N/A | N/A | N/A | N/A | N/A | N/A |
23 | Wang S, 2023 [41] | DR 14,2.75 no DR 7, 2.93 | no DR 8.46 ± 2.43; DR 8.81 ± 1.76 | no DR: 0.72 ± 0.14 DR 0.72 ± 0.14 | N/A | N/A | N/A | N/A | 1.002 (1.000–1.004)* |
24 | Yeter DY, 2022 [44] |  | no DR 8.09 ± 1.9; DR 8.3 ± 1.7 | N/A | N/A | 4.004 (1.656–9.685)* | N/A | N/A | N/A |
25 | Yue Song, 2015 [45] | no DR 5.38 ± 3.02; NPDR 10.44 ± 2.94 PDR 14.25 ± 3.94 | no DR 7.33 ± 2.22; NPDR 8.33 ± 2.22; PDR 8.53 ± 1.93 | No DR 60.00 ± 14.07 NPDR 58.75 ± 18.79 PDR 60.50 ± 24.44 | N/A | NS | NS | 54.574 (2.708–1099.907)* | N/A |
26 | Zeng J, 2022 [46] | No DR 2.00 ± 1.52; NPDR 10.00 ± 2.25 PDR 11.50 ± 3.00 | No DR 9.10 ± 0.88 NPDR 9.10 ± 0.95 PDR 10.30 ± 0.72 | No DR 56.40 ± 4.99 NPDR 60.50 ± 6.14 PDR 60.45 ± 8.46 | N/A | N/A | 1.020 (1.010–1.029)* | NS | N/A |
27 | Zhang P, 2021 [47] | DR 14.41 ± 5.82; no DR 11.65 ± 5.50 | no DR 7.10 ± 1.42; DR 8.00 ± 1.76 | no DR 1.55 ± 0.94 DR 1.52 ± 0.90 | N/A | 1.132 (1.053–1.217)* | N/A | N/A | N/A |